Rayca Precision

Personalized Cancer Research with OncoCrest™

Power your oncology research with AI-driven precision. OncoCrest™ is your gateway to data-driven insights, enhancing treatment decisions and transforming patient outcomes in the world of personalized cancer research.

OncoCrest™ Introduction Video

Dive into the predictive power of AI in precision oncology. Learn how OncoCrest™ use gene signatures to predict.

AI Based Predictions

Empowering Personalized Treatment Decisions for Optimal Outcomes

Predictive Drug Responses, Tailored to Your Research

Unlock the power of AI-driven predictions. OncoCrest™ analyzes transcriptomic sequencing data to provide personalized insights into drug responses, enabling clinical scientists to make informed decisions for individualized treatment strategies.

Stratified Patient Analysis, Unveiling New Avenues

Navigate cancer heterogeneity with confidence. OncoCrest™ utilizes advanced bioinformatics and deep learning to stratify patients based on genetic and molecular traits, revolutionizing treatment planning and paving the way for targeted therapies.

Bridging Research and Clinical Practice

Elevate evidence-based decision-making. OncoCrest™ seamlessly integrates public and curated datasets, closing the gap between research and clinical practice. Discover insights that drive advancements in cancer treatment and care.

Comprehensive Survival Analysis for Informed Choices

Uncover the future with survival insights. OncoCrest™ empowers you to predict patient outcomes, evaluate treatment efficacy, and delve into prognostic analyses. Make confident decisions backed by data for enhanced research outcomes.

Fusion Gene Analysis for Novel Targets

Explore the frontier of cancer mechanisms. OncoCrest™ detects and characterizes fusion events, predicting the folding of fusion proteins. Unearth novel therapeutic targets and dive into mechanistic exploration for innovative treatment strategies.

Personalized Prognostic Insights

See beyond the horizon of patient outcomes. OncoCrest™ offers survival analysis, cohort comparisons, and confidence intervals, enabling you to predict prognosis, identify risk factors, and guide therapeutic development with precision.

Unveiling Treatment Responses through Gene Expression Profiling

At OncoCrest™, we are at the forefront of leveraging cutting-edge technology to drive advancements in cancer therapeutics. Our innovative approach harnesses the power of gene expression profiling as a potent biomarker for predicting treatment responses with unparalleled accuracy.

The Power of AI and Gene Expression

In the complex landscape of cancer treatment, understanding how genes express themselves holds the key to unlocking personalized therapeutic strategies. OncoCrest™ integrates Artificial Intelligence (AI) with gene expression profiling to create a groundbreaking predictive modeling framework. This unique blend of computational biology and molecular biology principles empowers us to delve deep into the intricate mechanisms governing treatment responses.

Fusion Event Identification in Cancer

Dive into the intricate world of fusion events, where genes fuse to create novel genetic constructs. OncoCrest™ employs advanced bioinformatics algorithms to detect and characterize fusion events within transcriptomic sequencing data. By uncovering these fusion-driven mechanisms, we unravel the underlying molecular intricacies that drive tumor progression, providing a foundation for personalized treatment strategies.

Target Discovery and Validation

Witness the unfolding of molecular structures. OncoCrest™ goes beyond fusion event identification by predicting the 3D folding structure of fusion-derived proteins. This groundbreaking prediction enables the discovery of novel therapeutic targets, offering a deeper understanding of protein function and interactions that can guide innovative treatment development.

Unveiling Fusion-Driven Mechanisms

Peel back the layers of cancer heterogeneity. OncoCrest™ identifies fusion events that contribute to tumor complexity. These events may be key drivers of oncogenesis, opening new avenues for understanding disease progression. Harness the power of fusion event analysis to shed light on the intricate genetic landscape and unveil potential therapeutic targets.

Enhancing Drug Response Prediction

Elevate your treatment validation efforts. OncoCrest™ bridges the gap between prediction and validation by utilizing protein folding predictions to validate drug interactions. This unique approach enhances drug response prediction, ensuring that potential therapies are rigorously tested and validated in silico before advancing to further stages of development.

Embrace the Future of Precision Therapeutics

Precision Beyond Measure

By analyzing gene expression patterns, OncoCrest™ identifies subtle molecular signatures that influence how tumors react to treatments. This precision allows us to tailor therapies to individual patients, optimizing the potential for successful outcomes.

Uncovering Hidden Insights

Gene expression profiling offers a window into the underlying genetic and molecular factors that dictate how tumors respond to various treatments. OncoCrest™ uncovers these hidden insights, enabling researchers and to make informed decisions based on robust evidence.

Personalized Treatment Roadmaps

Our AI-powered framework transforms gene expression data into actionable insights. OncoCrest™ predicts how specific treatments will impact individual patients, providing a roadmap for personalized treatment strategies that target the unique characteristics of each tumor.

Accelerating Progress

By deciphering the language of gene expression, OncoCrest™ accelerates the pace of research and therapeutic development. Our advanced analytics enable rapid identification of potential drug candidates and enhance the efficiency of clinical trials.

Access OncoCrest™ Whitepaper

Dive into the predictive power of AI in precision oncology. Learn how OncoCrest™ revolutionizes patient stratification, treatment response prediction, and more.

Navigating OncoCrest™: Your Questions Answered

Discover the ins and outs of OncoCrest™, your gateway to AI-enabled precision oncology. Uncover answers to common queries about personalized treatment decisions, survival analysis, novel target identification, and more.

OncoCrest™ is an AI-enabled precision oncology platform developed by Rayca Precision. It utilizes advanced bioinformatics and deep learning to provide predictive insights, comprehensive survival analysis, and mechanistic exploration in personalized cancer research.

OncoCrest™ analyzes transcriptomic sequencing data to predict individualized drug responses, enabling clinical scientists to tailor treatment strategies based on patient-specific characteristics.


Cancer heterogeneity refers to the genetic and molecular diversity within tumors. OncoCrest™ uses advanced AI algorithms to stratify patients based on these traits, revolutionizing treatment planning and enabling targeted therapies.


OncoCrest™ seamlessly integrates public and curated datasets, allowing for evidence-based decision-making and fostering advancements in cancer research that can be directly translated into clinical applications.


Survival analysis in OncoCrest™ provides insights into patient outcomes, treatment efficacy, and prognosis. By analyzing survival curves, cohort comparisons, and confidence intervals, researchers can make informed decisions.


Yes, OncoCrest™ employs fusion gene analysis to detect and characterize fusion events in RNA-Seq data. It predicts the protein folding of fusion-derived proteins, uncovering potential new targets for therapeutic interventions.


OncoCrest™ is versatile and applicable across various cancer research areas, including biomarker discovery, treatment response prediction, survival analysis, and identification of molecular mechanisms.


Yes, OncoCrest™ is designed to accommodate researchers with varying levels of expertise. Its user-friendly interface and intuitive tools make it accessible for both beginners and experienced researchers.


Absolutely. OncoCrest™ is highly scalable and can efficiently analyze large-scale transcriptomic sequencing datasets, ensuring robust and accurate results even with extensive data.


Getting started with OncoCrest™ is easy. Simply request a demo through our website, and our team will guide you through the platform's features, functionalities, and how it can empower your personalized cancer research.

Request a Demo

Join the forefront of personalized oncology research with OncoCrest™. Request a demo today to witness the transformative capabilities of advanced bioinformatics and AI in optimizing treatment decisions, uncovering novel targets, and driving cancer research forward.

Rayca Precision Vision Intro Video

Unveiling Our Vision: Shaping the future of Bioinformatics and AI in drug discovery and clinical research.

OncoCrest™ Introduction Video

Dive into the predictive power of AI in precision oncology. Learn how OncoCrest™ use gene signatures to predict.

RSA2™ Introduction Video

Uncover the transformative capabilities of RSA2™ in preclinical, clinical research and drug discovery.